Citizens Downgrades Cellectis (CLLS) to Market Perform

September 15, 2026 3:16 AM

Citizens analyst Silvan Tuerkcan downgraded Cellectis (NASDAQ: CLLS) from Market Outperform to Market Perform.The analyst comments: “Cellectis announced a major ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found